Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation. Article uri icon

Overview

publication date

  • December 1, 2004

Research

keywords

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Piperazines
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Stem Cell Transplantation

Identity

Scopus Document Identifier

  • 10344241010

Digital Object Identifier (DOI)

  • 10.1016/j.bbmt.2004.09.004

PubMed ID

  • 15570257

Additional Document Info

volume

  • 10

issue

  • 12